Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  38 results for ""BNT162 Vaccine""

Your Filters

Publication : ebiomedicine Subject : antibodies, neutralizing Subject : covid-19 Subject : emotional engagement
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients.

  • Authors : Massa F; Department of Nephrology, Dialysis and Transplantation, Pasteur 2 Hospital, Nice University Hospital, 30 voie Romaine, 06300, Nice, France; Laboratory of Molecular Physio Medicine, University Côte d'Azur, CNRS, 28 Avenue de Valombrose, 06107, Nice, France

Subjects: Kidney Transplantation*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology SARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103679. Date of Electronic Publication: 2021 Nov 08.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.

  • Authors : Groß R; Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.; Zanoni M

Subjects: Immunization, Secondary*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*administration & dosage SARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103761. Date of Electronic Publication: 2021 Dec 17.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients.

  • Authors : Azzi L; Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Varese, Italy. Electronic address: .; Dalla Gasperina D

Subjects: Immunization, Secondary*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology

  • Source: EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103788. Date of Electronic Publication: 2021 Dec 23.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: EBioMedicine [EBioMedicine] 2024 May; Vol. 103, pp. 105100. Date of Electronic Publication: 2024 Apr 24.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers.

  • Authors : Moncunill G; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; CIBER de Enfermedades Infecciosas, Madrid, Spain. Electronic address: .

Subjects: Health Personnel*; 2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/*administration & dosage ; Antibody Formation/Antibody Formation/Antibody Formation/*drug effects

  • Source: EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103805. Date of Electronic Publication: 2022 Jan 12.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?

  • Authors : Silvestris N; Medical Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, 70124 Bari, Italy; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', 70124 Bari, Italy. Electronic address: .

Subjects: Immunity* ; Immunocompromised Host*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology

  • Source: EBioMedicine [EBioMedicine] 2021 Dec; Vol. 74, pp. 103733. Date of Electronic Publication: 2021 Dec 01.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response.

  • Authors : Ontañón J; Immunology Unit, Albacete General Hospital, c/ Hermanos Falcó 37, E-02008 Albacete, Spain.; Blas J

Subjects: Immunity, Humoral*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology ; COVID-19/COVID-19/COVID-19/*pathology

  • Source: EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103656. Date of Electronic Publication: 2021 Oct 30.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex.

  • Authors : Tang J; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993.; Grubbs G

Subjects: 2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/*immunology ; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*blood ; Antibody Affinity/Antibody Affinity/Antibody Affinity/*immunology SARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2021 Dec; Vol. 74, pp. 103748. Date of Electronic Publication: 2021 Dec 10.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.

  • Authors : Wang Y; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), No. 31 Huatuo Street, Daxing District, Beijing 102629, China. Electronic address: .

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*blood ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood ; COVID-19/COVID-19/COVID-19/*prevention & control SARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103677. Date of Electronic Publication: 2021 Nov 03.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.

  • Authors : Havervall S; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.; Marking U

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Antibody Formation/Antibody Formation/Antibody Formation/*immunology ; COVID-19/COVID-19/COVID-19/*immunology

  • Source: EBioMedicine [EBioMedicine] 2021 Aug; Vol. 70, pp. 103523. Date of Electronic Publication: 2021 Aug 12.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  38 results for ""BNT162 Vaccine""